Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy

Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer

(2012) K. Kron et al.   CLINICAL CANCER RESEARCH

Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer

(2012) Tsutomu Nishiyama   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma

(2012) Viviana P. Montecinos et al.   PLoS One

Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer

(2012) Alexandre Ingels et al.   Current Urology Reports

Primary human tumor xenografted models (‘tumorgrafts’) for good management of patients with cancer

(2011) Didier Decaudin   ANTI-CANCER DRUGS

Small Molecule Inhibitors Targeting the “Achilles' Heel” of Androgen Receptor Activity: Figure 1.

(2011) Marianne D. Sadar   CANCER RESEARCH

Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy

(2011) Y. Sun et al.   CANCER RESEARCH

Targeting Continued Androgen Receptor Signaling in Prostate Cancer

(2011) C. Massard et al.   CLINICAL CANCER RESEARCH

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

(2011) G. Attard et al.   CLINICAL CANCER RESEARCH

Novel agents and new therapeutics in castration-resistant prostate cancer

(2011) Yichao Wu et al.   CURRENT OPINION IN ONCOLOGY

A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer

(2011) M. Hidalgo et al.   MOLECULAR CANCER THERAPEUTICS

Hormone Depletion-Insensitivity of Prostate Cancer Cells Is Supported by the AR Without Binding to Classical Response Elements

(2011) Mesfin Gonit et al.   MOLECULAR ENDOCRINOLOGY

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

(2011) Yoko S DeRose et al.   NATURE MEDICINE

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

(2011) Jones T. Nauseef et al.   Nature Reviews Urology

Targeting 5α-reductase for prostate cancer prevention and treatment

(2011) Lucas P. Nacusi et al.   Nature Reviews Urology

Tissue Slice Grafts

(2010) Hongjuan Zhao et al.   AMERICAN JOURNAL OF PATHOLOGY

Tuberin Regulates E-Cadherin Localization

(2010) Elizabeth A. Barnes et al.   AMERICAN JOURNAL OF PATHOLOGY

Site-Dependent E-Cadherin Cleavage and Nuclear Translocation in a Metastatic Colorectal Cancer Model

(2010) María Virtudes Céspedes et al.   AMERICAN JOURNAL OF PATHOLOGY

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

(2010) Michel Bolla et al.   LANCET ONCOLOGY

Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells

(2010) Dejuan Kong et al.   PLoS One

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

(2009) Qianben Wang et al.   CELL

The multi-disciplinary management of high-risk prostate cancer

(2009) Jonathan C. Picard et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks

(2008) Hendrik Isbarn et al.   EUROPEAN UROLOGY